Average Co-Inventor Count = 11.21
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (18 from 329 patents)
2. Mirati Therapeutics, Inc. (7 from 38 patents)
3. Roche Palo Alto LLC (3 from 322 patents)
4. Celgene Corporation (2 from 550 patents)
5. Warner-lambert Company (1 from 2,538 patents)
6. Cogent Biosciences, Inc. (1 from 2 patents)
7. F. Hoffmann-la Roche Ag (168 patents)
23 patents:
1. 12351581 - Compounds for FGFR inhibition
2. 12187721 - Protein tyrosine phosphatase inhibitors
3. 11964989 - KRas G12D inhibitors
4. 11932633 - KRas G12C inhibitors
5. 11884664 - Protein tyrosine phosphatase inhibitors
6. 11634417 - Protein tyrosine phosphatase inhibitors
7. 11453683 - KRas G12D inhibitors
8. 11267812 - KRAS G12C inhibitors
9. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
10. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
11. 10689377 - KRas G12C inhibitors
12. 10633381 - KRas G12C inhibitors
13. 10189845 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
14. 10125134 - KRas G12C inhibitors
15. 9079890 - Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives